Koning Breast CT

The Koning Breast CT (KBCT) offers a pioneering approach to breast imaging by providing true 3D, isotropic imaging without the need for breast compression, enhancing patient comfort with prone positioning. Its rapid scan time of 7 seconds enables high throughput while maintaining superior detection capabilities, identifying smaller and earlier cancers effectively. The system is designed to match the radiation dose of traditional mammography, minimizing patient exposure. This advanced imaging technology promotes greater clinical insights while reducing recalls, thereby optimizing workflow efficiency for healthcare providers. With minimal training required, the KBCT supports improved economic outcomes by integrating capital equipment efficiency, potentially replacing multiple devices within a compact footprint. This leads to reduced facility modification costs and contributes to more sustainable healthcare practices. The benefits extend to patients as they experience greater compliance due to the non-invasive procedure and reduced discomfort. From an economic standpoint, the system assists in lowering costs per case, the overall cost of breast cancer management, and extraneous costs associated with false positives, making it a compelling choice for modern healthcare facilities seeking to enhance their breast imaging services.

Koning Breast CT

REVOLUTIONIZING THE BREAST IMAGING INDUSTRY

Koning True 3D Breast CT (KBCT) provides significant clinical and economic benefits to all parties in health care ecosystem!

• No breast compression with comfortable prone positioning
• Fast scan time (7 sec)
• True 3D detects smaller, earlier cancers resulting in no recalls
• Better clinical insight.
• True 3D isotropic imaging
• Higher throughput
• 1 Superior detection
• Equivalent radiation dose to mammography
• Minimal training required
• Better economics for providers
• Compelling fiscal sustainability
• Capital equipment efficiency – replaces multiple devices
• Small footprint, limited facility modifications … and payors.
• Greater patient compliance
• Reduce cost per case
• Reduce total cost of breast cancer
• Less extraneous costs from false positives